T-Cell Lymphomas, Version 2.2018 Featured Updates to the NCCN Guidelines

Steven M. Horwitz; Stephen M. Ansell; Weiyun Z. Ai; Jeffrey Barnes; Stefan K. Barta; Michael Choi; Mark W. Clemens; Ahmet Dogan; John P. Greer; Ahmad Halwani; M. Haverkos Bradley; Richard T. Hoppe; Eric Jacobsen; Deepa Jagadeesh; Youn H. Kim; Matthew A. Lunning; Amitkumar Mehta; Neha Mehta-Shah; Yahurio Oki; Elise A. Olsen; Barbara Pro; Saurabh A. Rajguru; Satish Shanbhag; Andrei Shustov; Lubomir Sokol; Pallawi Torka; Ryan Wilcox; Basem William; Jasmine Zain; Mary A. Dwyer; Hema Sundar

doi:10.6004/jnccn.2018.0007

T-Cell Lymphomas, Version 2.2018 Featured Updates to the NCCN Guidelines

Steven M. Horwitz
, Stephen M. Ansell
, Weiyun Z. Ai
, Jeffrey Barnes
, Stefan K. Barta
, Michael Choi
, Mark W. Clemens
, Ahmet Dogan
, John P. Greer
, Ahmad Halwani
, M. Haverkos Bradley
, Richard T. Hoppe
, Eric Jacobsen
, Deepa Jagadeesh
, Youn H. Kim
, Matthew A. Lunning
, Amitkumar Mehta
, Neha Mehta-Shah
, Yahurio Oki
, Elise A. Olsen

Barbara Pro, Saurabh A. Rajguru, Satish Shanbhag, Andrei Shustov, Lubomir Sokol, Pallawi Torka, Ryan Wilcox, Basem William, Jasmine Zain, Mary A. Dwyer, Hema Sundar

School of Medicine

Research output: Contribution to journal › Review article › peer-review

26 Scopus citations

Abstract

Natural killer (NK)/T-cell lymphomas are a rare and distinct subtype of non-Hodgkin's lymphomas. NK/T-cell lymphomas are predominantly extranodal and most of these are nasal type, often localized to the upper aerodigestive tract. Because extranodal NK/T-cell lymphomas (ENKL) are rare malignancies, randomized trials comparing different regimens have not been conducted to date and standard therapy has not yet been established for these patients. These NCCN Guidelines Insights discuss the recommendations for the diagnosis and management of patients with ENKL as outlined in the NCCN Guidelines for T-Cell Lymphomas.

Original language	English (US)
Pages (from-to)	123-135
Number of pages	13
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	16
Issue number	2
DOIs	https://doi.org/10.6004/jnccn.2018.0007
State	Published - Feb 1 2018

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2018.0007

Cite this

Horwitz, S. M., Ansell, S. M., Ai, W. Z., Barnes, J., Barta, S. K., Choi, M., Clemens, M. W., Dogan, A., Greer, J. P., Halwani, A., Bradley, M. H., Hoppe, R. T., Jacobsen, E., Jagadeesh, D., Kim, Y. H., Lunning, M. A., Mehta, A., Mehta-Shah, N., Oki, Y., ... Sundar, H. (2018). T-Cell Lymphomas, Version 2.2018 Featured Updates to the NCCN Guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 16(2), 123-135. https://doi.org/10.6004/jnccn.2018.0007

Horwitz, SM, Ansell, SM, Ai, WZ, Barnes, J, Barta, SK, Choi, M, Clemens, MW, Dogan, A, Greer, JP, Halwani, A, Bradley, MH, Hoppe, RT, Jacobsen, E, Jagadeesh, D, Kim, YH, Lunning, MA, Mehta, A, Mehta-Shah, N, Oki, Y, Olsen, EA, Pro, B, Rajguru, SA, Shanbhag, S, Shustov, A, Sokol, L, Torka, P, Wilcox, R, William, B, Zain, J, Dwyer, MA & Sundar, H 2018, 'T-Cell Lymphomas, Version 2.2018 Featured Updates to the NCCN Guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 16, no. 2, pp. 123-135. https://doi.org/10.6004/jnccn.2018.0007

@article{69843b26b4c44d2fb26e18ae138e0cdc,

title = "T-Cell Lymphomas, Version 2.2018 Featured Updates to the NCCN Guidelines",

abstract = "Natural killer (NK)/T-cell lymphomas are a rare and distinct subtype of non-Hodgkin's lymphomas. NK/T-cell lymphomas are predominantly extranodal and most of these are nasal type, often localized to the upper aerodigestive tract. Because extranodal NK/T-cell lymphomas (ENKL) are rare malignancies, randomized trials comparing different regimens have not been conducted to date and standard therapy has not yet been established for these patients. These NCCN Guidelines Insights discuss the recommendations for the diagnosis and management of patients with ENKL as outlined in the NCCN Guidelines for T-Cell Lymphomas.",

author = "Horwitz, \{Steven M.\} and Ansell, \{Stephen M.\} and Ai, \{Weiyun Z.\} and Jeffrey Barnes and Barta, \{Stefan K.\} and Michael Choi and Clemens, \{Mark W.\} and Ahmet Dogan and Greer, \{John P.\} and Ahmad Halwani and Bradley, \{M. Haverkos\} and Hoppe, \{Richard T.\} and Eric Jacobsen and Deepa Jagadeesh and Kim, \{Youn H.\} and Lunning, \{Matthew A.\} and Amitkumar Mehta and Neha Mehta-Shah and Yahurio Oki and Olsen, \{Elise A.\} and Barbara Pro and Rajguru, \{Saurabh A.\} and Satish Shanbhag and Andrei Shustov and Lubomir Sokol and Pallawi Torka and Ryan Wilcox and Basem William and Jasmine Zain and Dwyer, \{Mary A.\} and Hema Sundar",

note = "Publisher Copyright: {\textcopyright} JNCCN-Journal of the National Comprehensive Cancer Network.",

year = "2018",

month = feb,

day = "1",

doi = "10.6004/jnccn.2018.0007",

language = "English (US)",

volume = "16",

pages = "123--135",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Harborside Press",

number = "2",

}

TY - JOUR

T1 - T-Cell Lymphomas, Version 2.2018 Featured Updates to the NCCN Guidelines

AU - Horwitz, Steven M.

AU - Ansell, Stephen M.

AU - Ai, Weiyun Z.

AU - Barnes, Jeffrey

AU - Barta, Stefan K.

AU - Choi, Michael

AU - Clemens, Mark W.

AU - Dogan, Ahmet

AU - Greer, John P.

AU - Halwani, Ahmad

AU - Bradley, M. Haverkos

AU - Hoppe, Richard T.

AU - Jacobsen, Eric

AU - Jagadeesh, Deepa

AU - Kim, Youn H.

AU - Lunning, Matthew A.

AU - Mehta, Amitkumar

AU - Mehta-Shah, Neha

AU - Oki, Yahurio

AU - Olsen, Elise A.

AU - Pro, Barbara

AU - Rajguru, Saurabh A.

AU - Shanbhag, Satish

AU - Shustov, Andrei

AU - Sokol, Lubomir

AU - Torka, Pallawi

AU - Wilcox, Ryan

AU - William, Basem

AU - Zain, Jasmine

AU - Dwyer, Mary A.

AU - Sundar, Hema

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Natural killer (NK)/T-cell lymphomas are a rare and distinct subtype of non-Hodgkin's lymphomas. NK/T-cell lymphomas are predominantly extranodal and most of these are nasal type, often localized to the upper aerodigestive tract. Because extranodal NK/T-cell lymphomas (ENKL) are rare malignancies, randomized trials comparing different regimens have not been conducted to date and standard therapy has not yet been established for these patients. These NCCN Guidelines Insights discuss the recommendations for the diagnosis and management of patients with ENKL as outlined in the NCCN Guidelines for T-Cell Lymphomas.

AB - Natural killer (NK)/T-cell lymphomas are a rare and distinct subtype of non-Hodgkin's lymphomas. NK/T-cell lymphomas are predominantly extranodal and most of these are nasal type, often localized to the upper aerodigestive tract. Because extranodal NK/T-cell lymphomas (ENKL) are rare malignancies, randomized trials comparing different regimens have not been conducted to date and standard therapy has not yet been established for these patients. These NCCN Guidelines Insights discuss the recommendations for the diagnosis and management of patients with ENKL as outlined in the NCCN Guidelines for T-Cell Lymphomas.

UR - https://www.scopus.com/pages/publications/85042114712

UR - https://www.scopus.com/pages/publications/85042114712#tab=citedBy

U2 - 10.6004/jnccn.2018.0007

DO - 10.6004/jnccn.2018.0007

M3 - Review article

C2 - 29439173

AN - SCOPUS:85042114712

SN - 1540-1405

VL - 16

SP - 123

EP - 135

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 2

ER -

T-Cell Lymphomas, Version 2.2018 Featured Updates to the NCCN Guidelines

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this